ScinoPharm, a Taiwan-based supplier of active pharmaceutical ingredients, has started construction of a new plant and R&D centre in Changshu, Jiangsu province. It should be operational in 2011.

“The Changshu plant will serve as a launching pad for the rapidly expanding Chinese pharmaceutical market as well as a back-up site to our customers,” said Dr Jo Shen, president and CEO of the company.